Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 1.35 million during the last session, with the company’s beta value hitting -0.41.The LYEL share’s 52-week high
In the last trading session, 1.11 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.34. With the company’s per share
In the last trading session, 1.0 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.34. With the company’s per share
In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 1.74 million shares changing hands with its beta currently measuring -0.46. Company’s recent per share price
Lyell Immunopharma Inc (NASDAQ:LYEL) has a beta value of -0.48 and has seen 1.97 million shares traded in the last trading session. The company, currently
During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 2.12 million, with the beta value of the company hitting -0.54. At the end
In the last trading session, 1.87 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.54. Most recently the company’s
In the last trading session, 3.46 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.54. Most recently the company’s
Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 2.41 million during the last session, with the company’s beta value hitting -0.53. At the close of
During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.43 million, with the beta value of the company hitting -0.53. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
